tirzepatide · GIP/GLP-1 receptor agonist

Zepbound

Manual-verified official Lilly anchors while backend fetch remains blocked.

Manual verified

Basis split

Why are there two numbers?

Lilly publishes a label-safe prescribing-information result and a rounded consumer headline. Keep the label anchor as the comparable clinical number and keep the headline as attributed context.

Efficacy anchors

2 anchors

  • Label-safe anchor

    LabelWeek 72

    Trial: Study 1

    Adults without diabetes

    20.9%

    Zepbound Prescribing Information

    Apr 12, 2026 5:00 PM

    Why this number?

    Mean body-weight change at Week 72 for 15 mg in Study 1.

    Dose context: 15 mg

  • Consumer headline

    HeadlineWeek 72

    Trial: Consumer/HCP headline

    Rounded consumer-facing headline

    ~21%

    What Is Zepbound?

    Apr 12, 2026 5:05 PM

    Why this number?

    Rounded consumer-facing efficacy claim of about 21%.

    Dose context: highest dose

Price anchors

3 anchors

  • Starting self-pay

    Starting

    Dose context: 2.5 mg

    Program: Self Pay Journey Program

    $299/mo

    Zepbound Savings

    Apr 12, 2026 5:10 PM

    Why this number?

    Current self-pay program pricing for 2.5 mg.

    Official starting self-pay program price

    Patient segment: cash_pay

    Starting price under current self-pay program.

  • Step-up self-pay

    Step-Up

    Dose context: 5 mg

    Program: Self Pay Journey Program

    $399/mo

    Zepbound Savings

    Apr 12, 2026 5:10 PM

    Why this number?

    Step-up self-pay program price for 5 mg.

    Current self-pay program pricing for 5 mg.

    Patient segment: cash_pay

    Intermediate self-pay program price for 5 mg.

  • Maintenance self-pay

    Maintenance

    Dose context: 7.5 mg, 10 mg, 12.5 mg, 15 mg

    Program: Self Pay Journey Program

    $449/mo

    Zepbound Savings

    Apr 12, 2026 5:10 PM

    Why this number?

    Maintenance self-pay program price for 7.5 mg and above.

    Current self-pay program pricing for higher maintenance doses.

    Patient segment: cash_pay

    Current maintenance self-pay price for higher doses.

Source ledger

3 linked

Timeline

Change history

View all changes →
low severity

Observed Zepbound price anchor maintenance_self_pay

Observed Zepbound maintenance_self_pay at $449/month from Zepbound Savings.

View source
low severity

Observed Zepbound price anchor step_up_self_pay

Observed Zepbound step_up_self_pay at $399/month from Zepbound Savings.

View source
low severity

Observed Zepbound price anchor starting_self_pay

Observed Zepbound starting_self_pay at $299/month from Zepbound Savings.

View source
low severity

Observed Zepbound efficacy anchor company_headline

Observed Zepbound company_headline efficacy anchor at 21% from What Is Zepbound?.

View source
low severity

Observed Zepbound efficacy anchor label_absolute

Observed Zepbound label_absolute efficacy anchor at 20.9% from Zepbound Prescribing Information.

View source